Suwanpakdee Detchvijitr, Laohapand Chalida, Moolasart Visal, Lomtong Prasong, Krairojananan Nat, Srisawat Phutsapong, Watanaveeradej Veerachai
Department of Pediatrics, Phramongkutklao Hospital, Bangkok, Thailand.
J Med Assoc Thai. 2012 May;95 Suppl 5:S80-5.
To identify seroprevalence of varicella and the relationship with their histories of experiences of varicella diseases and to provide appropriate immunization against varicella, mumps, measles, rubella and hepatitis B to medical students.
All of the medical students were eligible for participation after informed consents. Immunization history against varicella, mumps, measles, rubella (MMR) and hepatitis B were obtained from a questionnaire. A blood sample was obtained from each student for IgG antibody against VZV by ELISA. Medical students with an uncertain history or no documentation of hepatitis B vaccination were tested for HBsAg and anti-HBcIgG by ELISA.
There were 383 medical students enrolled. The mean age at enrollment was 21.6 years (median 21.4 years; range 18-25.8 years). Of 383 medical students, 372 (97.2%) had documents of receiving MMR immunizations. The blood samples were obtained from 374 of 383 (97.6%) medical students to identify the immunity against varicella zoster virus (VZV) and the seroprevalence rate was 92%. Using VZVIgG antibody detection as a standard test, history of experience of varicella disease provided positive predictive value of 99.3% (148/149). Of 383 medical students, 277 (72.3%) were tested for hepatitis B markers and 243 (87.7%) students showed negative results. The prevalence of HBsAg carriers was 0.01% (4/383).
Suboptimal immunities against vaccine preventable diseases could be demonstrated in the medical students including varicella and hepatitis B. New recommendations of immunizations against varicella, MMR and hepatitis B viruses for a particular group of the population were provided.
确定水痘的血清流行率及其与水痘病史的关系,并为医学生提供针对水痘、腮腺炎、麻疹、风疹和乙型肝炎的适当免疫接种。
所有医学生在获得知情同意后均有资格参与。通过问卷调查获取水痘、腮腺炎、麻疹、风疹(MMR)和乙型肝炎的免疫接种史。从每位学生采集血液样本,采用酶联免疫吸附测定法(ELISA)检测抗水痘带状疱疹病毒(VZV)的IgG抗体。对病史不确定或无乙肝疫苗接种记录的医学生,采用ELISA检测HBsAg和抗-HBcIgG。
共纳入383名医学生。入学时的平均年龄为21.6岁(中位数21.4岁;范围18 - 25.8岁)。383名医学生中,372名(97.2%)有MMR免疫接种记录。从383名中的374名(97.6%)医学生采集了血液样本,以确定对水痘带状疱疹病毒(VZV)的免疫力,血清流行率为92%。以VZV IgG抗体检测作为标准检测方法,水痘病史的阳性预测值为99.3%(148/149)。383名医学生中,277名(72.3%)接受了乙肝标志物检测,243名(87.7%)学生结果为阴性。HBsAg携带者的患病率为0.01%(4/383)。
医学生中对疫苗可预防疾病的免疫力欠佳,包括水痘和乙型肝炎。针对特定人群提供了关于水痘、MMR和乙型肝炎病毒免疫接种的新建议。